Rehabilitation after bone marrow transplant- what is the impact on patient outcomes?The REBOOT trial

Not Applicable

Recruiting

• Conditions: Malignancy; Cancer - Any cancer; Bone Marrow Transplant

• Registration Number: ACTRN12622001071718
• Lead Sponsor: niversity of Melbourne

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2022-08-03
• Last Update Posted: 18 March 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 170

Inclusion Criteria

Patients who are 18 years or over, able to ambulate independently, are 30 days (+/-10 days) after an autologous or allogeneic BMT for haematological cancers, who are able to provide written informed consent and are proficient in English to understand exercise testing and training instructions as well as outcome assessments.

Exclusion Criteria

Concurrent, actively treated other malignancy or history of other malignancy treated within the past year, severe or unstable neurological, cardiorespiratory or musculoskeletal disease or mental illness that might compromise ability to perform exercise, unstable psychiatric or cognitive disorders, ECOG performance status >2.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Health-related quality of life (Physical Function domain of the EORTC QLQ-C30)[ Baseline (Week 0) and Follow-Up 1 (Week 9)]